Bradley Liestenfeltz

Bradley Liestenfeltz

Auto-generated profile, based on publicly available information

Bradley Liestenfeltz

Department of Health Behavior and Biological Sciences, School of Nursing, University of Michigan, Ann Arbor, MI, United States

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2019 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
DGDina Griauzde
Dina Griauzde
JKJeffrey T Kullgren
Jeffrey T Kullgren
BLBrad Liestenfeltz
Brad Liestenfeltz
TATahoora Ansari
Tahoora Ansari
EJEmily H Johnson
Emily H Johnson
MHMichele Heisler
Michele Heisler
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Despite evidence that Diabetes Prevention Programs (DPPs) can delay or prevent progression to type 2 diabetes mellitus (T2DM), few individuals with prediabetes enroll in offered programs. This may be in part because many individuals with prediabetes have low levels of autonomous motivation (i.e. motivation that arises from internal sources) to prevent T2DM. Objective: To examine: 1) whether adults with prediabetes who had previously declined participation in local and online DPPs that were offered at no out-of-pocket cost would agree to participate in and engage with a mobile health (mHealth) intervention designed to increase autonomous motivation for healthy behaviors; 2) to examine changes in autonomous motivation among adults offered two versions of the mHealth program compared to usual care; and 3) to assess satisfaction with and recommended changes to the program. Methods: This was a 12-week, parallel, 3-arm pilot randomized controlled trial. Participants were randomized to (1) a group who received information about prediabetes and strategies to prevent T2DM (control); (2) a group who received an mHealth smartphone application that aims to increase autonomous motivation among users (app-only); or (3) a group who received the application plus a physical activity tracker and wireless-enabled digital scale for self-monitoring (app-plus). We evaluated rates of intervention uptake (number of individuals enrolled / number of individuals assessed for eligibility), retention (number of 12-week survey completers / number of participants), and adherence (number of device-usage days). Using difference-in-difference analysis, we examined change in autonomous motivation (measured using the Treatment Self-Regulation Questionnaire). We conducted post-intervention qualitative interviews with participants. Results: Sixty-nine of 244 (28%) of eligible individuals were randomized. Fifty-five individuals (80%) completed the 12-week survey. Retention rates were significantly greater among app-plus participants than participants in the other two study arms combined (p=0.004, 2). There were no significant differences in adherence rates between app-only and app-plus participants (43 days vs. 37 days; p=0.34). Among all participants, mean autonomous motivation measures were relatively high at baseline (6.0 of 7.0 scale), and there were no statistically significant within-group or between-group differences in follow-up scores. In qualitative interviews (n=15), participants identified reasons that they enjoyed using the app (e.g. encouraged self-reflection), reasons that they did not enjoy using the app (e.g., did not consider personal circumstances), and strategies to improve the intervention (e.g., increased interpersonal contact). Conclusions: Among individuals with prediabetes who did not engage in free DPP programs, this mHealth intervention was feasible and acceptable. These findings underscore the importance of developing and testing novel strategies of varying intensities and delivery modalities to meet the diverse needs and preferences of the many individuals with prediabetes who do not participate in offered formal programs. Future work should (1) examine the effectiveness of a refined intervention on clinically-relevant outcomes (e.g. weight loss) among a larger population of DPP non-enrollees with low baseline autonomous motivation and (2) identify other factors associated with DPP non-enrollment, which may serve as additional potential targets for interventions.

9 September 2020 in JMIR Diabetes
Verified
Journal Article
Open access
LSLaura R Saslow
Laura R Saslow
JMJudith Tedlie Moskowitz
Judith Tedlie Moskowitz
AMAshley Mason
Ashley Mason
JDJennifer Daubenmier
Jennifer Daubenmier
BLBradley Liestenfeltz
Bradley Liestenfeltz
FHFrederick M Hecht
Frederick M Hecht
Background: Adults with type 2 diabetes may experience health benefits, including glycemic control and weight loss, from following a very low–carbohydrate, ketogenic (VLC) diet. However, it is unclear which ancillary strategies may enhance these effects. Objective: This pilot study aims to estimate the effect sizes of 3 intervention enhancement strategies (text messages, gifts, and breath vs urine ketone self-monitoring) that may improve outcomes of a 12-month web-based ad libitum VLC diet and lifestyle intervention for adults with type 2 diabetes. The primary intervention also included other components to improve adherence and well-being, including positive affect and mindfulness as well as coaching. Methods: Overweight or obese adults (n=44; BMI 25-45 kg/m2) with type 2 diabetes (glycated hemoglobin [HbA1c] ≥6.5%), who had been prescribed either no glucose-lowering medications or metformin alone, participated in a 12-month web-based intervention. Using a 2×2×2 randomized factorial design, we compared 3 enhancement strategies: (1) near-daily text messages about the intervention’s recommended behaviors (texts n=22 vs no texts n=22), (2) mailed gifts of diet-relevant foods and cookbooks (6 rounds of mailed gifts n=21 vs no gifts n=23), and (3) urine- or breath-based ketone self-monitoring (urine n=21 vs breath n=23). We assessed HbA1c and weight at baseline and at 4, 8, and 12 months. We evaluated whether each strategy exerted a differential impact on HbA1c and weight at 12 months against an a priori threshold of Cohen d of 0.5 or greater. Results: We retained 73% (32/44) of the participants at 12 months. The intervention, across all conditions, led to improvements in glucose control and reductions in body weight at the 12-month follow-up. In intent-to-treat (ITT) analyses, the mean HbA1c reduction was 1.0% (SD 1.6) and the mean weight reduction was 5.3% (SD 6.0), whereas among study completers, these reductions were 1.2% (SD 1.7) and 6.3% (SD 6.4), respectively, all with a P value of less than .001. In ITT analyses, no enhancement strategy met the effect size threshold. Considering only study completers, 2 strategies showed a differential effect size of at least a d value of 0.5 or greater Conclusions: Text messages, gifts of food and cookbooks, and urine-based ketone self-monitoring may potentially enhance the glycemic or weight loss benefits of a web-based VLC diet and lifestyle intervention for individuals with type 2 diabetes. Future research could investigate other enhancement strategies to help create even more effective solutions for the treatment of type 2 diabetes. Trial Registration: ClinicalTrials.gov NCT02676648; http://clinicaltrials.gov/ct2/show/NCT02676648

11 May 2023 in JMIR Diabetes
Verified
Journal Article
Open access
LSLaura R Saslow
Laura R Saslow
AMAmanda Missel
Amanda Missel
AOAlison O’bRien
Alison O’bRien
SKSarah Kim
Sarah Kim
FHFrederick M Hecht
Frederick M Hecht
JAJames E Aikens
James E Aikens
Background: A very low–carbohydrate (VLC) nutritional strategy may improve glycemic control and weight loss in adults with type 2 diabetes (T2D). However, the supplementary behavioral strategies that might be able to improve outcomes using this nutritional strategy are uncertain. Objective: This study aims to compare the impact of adding 3 different supplementary behavioral strategies to a web-based VLC diet intervention. To our knowledge, this is the first trial to randomize participants to different frequencies of dietary self-monitoring. Methods: The study included 112 overweight adults with T2D (hemoglobin A1c ≥6.5%) taking no antiglycemic medications or only metformin. They received a remotely delivered 12-month VLC diet intervention. Participants were randomly assigned through a full factorial 2×2×2 design to supplementary strategies: either daily or monthly dietary self-monitoring, either mindful eating training or not, and either positive affect skills training or not. Our research goal was to determine whether 3 different supplemental strategies had at least a medium effect size (Cohen d=0.5). Results: Overall, the VLC intervention led to statistically significant improvements in glycemic control (−0.70%, 95% CI −1.04% to −0.35%; P<.001), weight loss (−6.82%, 95% CI −8.57% to −5.08%; P<.001), and depressive symptom severity (Cohen d −0.67, 95% CI −0.92 to −0.41; P<.001). Furthermore, 30% (25/83) of the participants taking metformin at baseline reduced or discontinued their metformin. Only 1 Cohen d point estimate reached 0.5; daily (vs monthly) dietary self-monitoring had a worse impact on depressive symptoms severity (Cohen d=0.47, 95% CI −0.02 to 0.95; P=.06). None of the strategies had a statistically significant effect on outcomes. For changes in our primary outcome, hemoglobin A1c, the daily (vs monthly) dietary self-monitoring impact was 0.42% (95% CI −0.28% to 1.12%); for mindful eating, it was −0.47% (95% CI −1.15% to 0.22%); and for positive affect, it was 0.12% (95% CI −0.57% to 0.82%). Other results for daily (vs monthly) dietary self-monitoring were mixed, suggesting an increase in weight (0.98%) and depressive symptoms (Cohen d=0.47), less intervention satisfaction (Cohen d=−0.20), more sessions viewed (3.02), and greater dietary adherence (Cohen d=0.24). For mindful eating, the results suggested a benefit for dietary adherence (Cohen d=0.24) and intervention satisfaction (Cohen d=0.30). For positive affect, the results suggested a benefit for depressive symptoms (Cohen d=−0.32), the number of sessions viewed (3.68), dietary adherence (Cohen d=0.16), and intervention satisfaction (Cohen d=0.25). Conclusions: Overall, our results support the use of a VLC diet intervention in adults with T2D. The addition of monthly (not daily) dietary self-monitoring, mindful eating, and positive affect skills training did not show a definitive benefit, but it is worth further testing. Trial Registration: ClinicalTrials.gov NCT03037528; https://clinicaltrials.gov/ct2/show/NCT03037528

1 July 2021 in Nursing Outlook
Verified
Journal Article
Open access
CPCarri Polick
Carri Polick
YCYoumin Cho
Youmin Cho
MHMelissa L. Harris
Melissa L. Harris
FJFlorence U U Johnson
Florence U U Johnson
JGJosephine R. Granner
Josephine R. Granner
WZWeijiao Zhou
Weijiao Zhou

9 June 2018 in JMIR Preprints
Verified
Preprint
Open access
DGDina Griauzde
Dina Griauzde
JKJeffrey T. Kullgren
Jeffrey T. Kullgren
BLBrad Liestenfeltz
Brad Liestenfeltz
TATahoora Ansari
Tahoora Ansari
EJEmily H Johnson
Emily H Johnson
MHMichele Heisler
Michele Heisler
BACKGROUND Despite evidence that Diabetes Prevention Programs (DPPs) can delay or prevent progression to type 2 diabetes mellitus (T2DM), few individuals with prediabetes enroll in offered programs. This may be in part because many individuals with prediabetes have low levels of autonomous motivation (ie, motivation that arises from internal sources) to prevent T2DM. OBJECTIVE This study aims to examine the feasibility and acceptability of a mobile health (mHealth) intervention designed to increase autonomous motivation and healthy behaviors among adults with prediabetes who previously declined participation free DPPs. In addition, the study aims to examine changes in autonomous motivation among adults offered 2 versions of the mHealth program compared with an information-only control group. METHODS In this 12-week, parallel, 3-arm, mixed-methods pilot randomized controlled trial, participants were randomized to (1) a group that received information about prediabetes and strategies to prevent T2DM (control); (2) a group that received a mHealth app that aims to increase autonomous motivation among users (app-only); or (3) a group that received the app plus a physical activity tracker and wireless-enabled digital scale for self-monitoring (app-plus). Primary outcome measures included rates of intervention uptake (number of individuals enrolled/number of individuals assessed for eligibility), retention (number of 12-week survey completers/number of participants), and adherence (number of device-usage days). The secondary outcome measure was change in autonomous motivation (measured using the Treatment Self-Regulation Questionnaire), which was examined using difference-in-difference analysis. Furthermore, we conducted postintervention qualitative interviews with participants. RESULTS Overall, 28% (69/244) of eligible individuals were randomized; of these, 80% (55/69) completed the 12-week survey. Retention rates were significantly higher among app-plus participants than participants in the other 2 study arms combined (P=.004, χ2). No significant differences were observed in adherence rates between app-only and app-plus participants (43 days vs 37 days; P=.34). Among all participants, mean autonomous motivation measures were relatively high at baseline (6.0 of 7.0 scale), with no statistically significant within- or between-group differences in follow-up scores. In qualitative interviews (n=15), participants identified reasons that they enjoyed using the app (eg, encouraged self-reflection), reasons that they did not enjoy using the app (eg, did not consider personal circumstances), and strategies to improve the intervention (eg, increased interpersonal contact). CONCLUSIONS Among individuals with prediabetes who did not engage in free DPPs, this mHealth intervention was feasible and acceptable. Future work should (1) examine the effectiveness of a refined intervention on clinically relevant outcomes (eg, weight loss) among a larger population of DPP nonenrollees with low baseline autonomous motivation and (2) identify other factors associated with DPP nonenrollment, which may serve as additional potential targets for interventions. CLINICALTRIAL ClinicalTrials.gov NCT03025607; https://clinicaltrials.gov/ct2/show/NCT03025607 (Archived by WebCite at http://www.webcitation.org/73cvaSAie)

15 November 2019 in JMIR Preprints
Verified
Preprint
Open access
LSLaura R Saslow
Laura R Saslow
JMJudith Tedlie Moskowitz
Judith Tedlie Moskowitz
AMAshley Mason
Ashley Mason
JDJennifer Daubenmier
Jennifer Daubenmier
BLBradley Liestenfeltz
Bradley Liestenfeltz
FHFrederick M Hecht
Frederick M Hecht
BACKGROUND Adults with type 2 diabetes may experience health benefits, including glycemic control and weight loss, from following a very low–carbohydrate, ketogenic (VLC) diet. However, it is unclear which ancillary strategies may enhance these effects. OBJECTIVE This pilot study aims to estimate the effect sizes of 3 intervention enhancement strategies (text messages, gifts, and breath vs urine ketone self-monitoring) that may improve outcomes of a 12-month web-based ad libitum VLC diet and lifestyle intervention for adults with type 2 diabetes. The primary intervention also included other components to improve adherence and well-being, including positive affect and mindfulness as well as coaching. METHODS Overweight or obese adults (n=44; BMI 25-45 kg/m2) with type 2 diabetes (glycated hemoglobin [HbA1c] ≥6.5%), who had been prescribed either no glucose-lowering medications or metformin alone, participated in a 12-month web-based intervention. Using a 2×2×2 randomized factorial design, we compared 3 enhancement strategies: (1) near-daily text messages about the intervention’s recommended behaviors (texts n=22 vs no texts n=22), (2) mailed gifts of diet-relevant foods and cookbooks (6 rounds of mailed gifts n=21 vs no gifts n=23), and (3) urine- or breath-based ketone self-monitoring (urine n=21 vs breath n=23). We assessed HbA1c and weight at baseline and at 4, 8, and 12 months. We evaluated whether each strategy exerted a differential impact on HbA1c and weight at 12 months against an a priori threshold of Cohen d of 0.5 or greater. RESULTS We retained 73% (32/44) of the participants at 12 months. The intervention, across all conditions, led to improvements in glucose control and reductions in body weight at the 12-month follow-up. In intent-to-treat (ITT) analyses, the mean HbA1c reduction was 1.0% (SD 1.6) and the mean weight reduction was 5.3% (SD 6.0), whereas among study completers, these reductions were 1.2% (SD 1.7) and 6.3% (SD 6.4), respectively, all with a P value of less than .001. In ITT analyses, no enhancement strategy met the effect size threshold. Considering only study completers, 2 strategies showed a differential effect size of at least a d value of 0.5 or greater CONCLUSIONS Text messages, gifts of food and cookbooks, and urine-based ketone self-monitoring may potentially enhance the glycemic or weight loss benefits of a web-based VLC diet and lifestyle intervention for individuals with type 2 diabetes. Future research could investigate other enhancement strategies to help create even more effective solutions for the treatment of type 2 diabetes. CLINICALTRIAL ClinicalTrials.gov NCT02676648; http://clinicaltrials.gov/ct2/show/NCT02676648